Résumé
Objective: Compare quality of life in two group of patients with endometriosis Material and methods: Observational, analytical and cross-sectional study. We included 60 women between 20-40 years with endometriosis who underwent surgical and pharmacological treatment with two different schemes, at Angeles Pedregal Hospital from 2019-2022. Group A was treated with peritonectomy + progestin (desogestrel 0.075 mg orally every 24 h) for 3 months, and group B with electrofulguration + GnRH agonist (leuprorelin 3.75 mg intramuscularly every 28 days) for 3 months. EHP-5 was applied prior and 6 months after treatment. When comparing scores before and after treatment in the overall Results: series of patients, both groups signicantly improved all items of EHP-5. Both groups had an improvement in Conclusions: quality of life at 6 months of follow-up
Résumé
The occurrence of Enterocytozoon hepatopenaei in Penaeus vannamei samples were collected from Maharashtra and Gujarat farms. In the present study, shrimp samples from various shrimp ponds from two districts of Maharashtra and two districts of Gujarat were collected over a period of one year (February 2016 to April 2017). A total of 4513 shrimp samples were assessed for the presence of EHP by molecular characterization. Out of shrimp samples analysed, 31.2% samples were positive for EHP. The screening of EHP was done by single step and nested PCR targeting spore wall protein gene (SWP) of EHP resulting in product size of 514 bp and 148 bp for EHP respectively
Résumé
Objective • To evaluate the reliability and validity of the Chinese version of the endometriosis health profile-5 (EHP-5) and to evaluate whether patients with different syndromes can be well discriminated with EHP-5. Methods • A total of 102 patients with pathologically proven endometriosis completed the questionnaire. The reliability and internal consistency of the Chinese version of EHP-5 were assessed by Cronbach's α coefficient. Creteria validity of the Chinese version of EHP-5 was investigated by comparing it with the EuroQol five-dimension questionnaire (EQ-5D). The patients were further subdivided into two subgroups according to the symptom of dysmenorrhea, dysmenorrhea, menstrual disorder or infertility. The scores in the five items of core questionnaire were compared between asymptomatic and symptomatic patients using Mann-Whitney U test. Results • The Cronbach's α coefficient was 0.877 for five items from the core questionnaire, and 0.843 for six items from the modular questionnaire. The internal consistency also showed satisfactory result (Cronbach's α>0.7). The correlations of related subscale scores between EHP-5 and EQ-5D were significant in some dimensions. There was significant differences in scores between asymptomatic and symptomatic subgroups divided by the symptom of dysmenorrhea or dyspareunia. But no significant difference was founds in scores between asymptomatic and symptomatic subgroups divided by the symptom of menstrual disorders or infertility. Conclusion • The Chinese version of EHP-5 is an acceptable, reliable and valid measure of quality of life in endometriosis patients with the symptom of dysmenorrhea or dysmenorrhea. However, EHP-5 could not well discriminate endometriosis patients with the symptom of menstrual disorder or infertility. More specific items are necessary so as to make EHP-5 an intervention tool for the prognosis and follow-up of patients with different symptoms.